In Brief: Imodium A-D Chewable Tablets
This article was originally published in The Tan Sheet
Executive Summary
Imodium A-D Chewable Tablets: To be introduced later this year, new dosage form of McNeil Consumer Products' loperamide anti-diarrheal (NDA 20-448) is approved by FDA July 24. Liquid, caplet and capsule forms of the product are marketed. The dosage form was designated "approvable" by the agency in May 1996 ("The Tan Sheet" Aug. 5, 1996, In Brief). McNeil is planning to launch another new Imodium product, Imodium Advanced, with loperamide and simethicone, later this year after receiving FDA approval June 26 ("The Tan Sheet" June 30, p. 2)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning